Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2020-12-01
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus
NCT05443516
Prediction of Outcome of Lupus Nephritis
NCT02403115
Prediction of Lupus Renal Flares Study
NCT05362812
T Regulatory Cells IN LUPUS NEPHRITIS
NCT06428539
Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)?
NCT03664908
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lupus nephritis +ve
This group consists of patients with Lupus nephritis
Blood sampling
Blood sampling will be performed to allow analyses of epigenetic markers
Lupus nephritis -ve
This group consist of patients with SLE without Lupus nephritis
Blood sampling
Blood sampling will be performed to allow analyses of epigenetic markers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sampling
Blood sampling will be performed to allow analyses of epigenetic markers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* a subgroup requires the presence of Lupus nephritis (no restriction to specific LN histologic subtypes)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King's College London
OTHER
Università degli Studi di Brescia
OTHER
University of Göttingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Korsten
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Center Göttingen
Göttingen, Lower Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
28/9/17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.